Mantle cell lymphoma-like lymphomas in c-myc-3'RR/p53+/- mice and c-myc-3'RR/Cdk4R24C mice: Differential oncogenic mechanisms but similar cellular origin

Oncotarget

Volumn 3, Issue 5, 2012, Pages 586-593

  Rouaud, Pauline ^a   Fiancette, Rémi ^a   Vincent Fabert, Christelle ^a   Magnone, Virginie ^b   Cogné, Michel ^a   Dubus, Pierre ^c   Denizot, Yves ^a  

^a UNIVERSITÉ DE LIMOGES   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

C myc; Mantle cell lymphoma

Indexed keywords

ARGININE; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYSTEINE; MYC PROTEIN; PROTEIN P53; CDK4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CDK4 GENE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC VARIABILITY; MANTLE CELL LYMPHOMA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE C MYC; TRANSGENIC MOUSE; TUMOR MODEL; TUMOR SUPPRESSOR GENE; UNINDEXED SEQUENCE; ANIMAL; CELL TRANSFORMATION; GENETICS; HUMAN; MUTATION; ONCOGENE MYC; PATHOLOGY;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE 4; GENE EXPRESSION PROFILING; GENES, MYC; HUMANS; LYMPHOMA, MANTLE-CELL; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; MUTATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84867285681     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.474     Document Type: Article

References (16)

1. Jares P, Campo E: Advances in the understanding of mantle cell lymphoma. Br J Haematol 2008;142:149-165.
2. Smith MR, Joshi I, Jin F, Al-Saleem T: Murine model for mantle cell lymphoma. Leukemia 2006;20:891-893.
3. Ford R J, Shen L, Lin-Lee YC, Pham LV, Multani A, Zhou HJ, Tamayo AT, Zhang C, Hawthorn L, Cowell JK, Ambrus JL Jr: Development of a murine model for blastoid variant mantle-cell lymphoma. Blood 2007;109:4899-4906.
4. Truffinet V, Pinaud E, Cogné N, Petit B, Guglielmi L, Cogné M, Denizot Y: The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype. J Immunol 2007;179:6033-6042.
5. Vincent-Fabert C, Fiancette R, Rouaud P, Baudet C, Truffinet V, Magnone V, Guillaudeau A, Cogné M, Dubus P, Denizot Y: A defect of the INK4-Cdk4 checkpoint and c-myc collaborate in blastoid mantle cell lymphoma (MCL)-like lymphoma formation in mice. Am J Pathol 2012;180:1688-1701.
6. Fiancette R, Rouaud P, Vincent-Fabert C, Laffleur B, Magnone V, Cogné M, Denizot Y: A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene. J Immunol 2011;187: 5772-5782.
7. Vincent-Fabert C, Fiancette R, Cogné M, Pinaud E, Denizot Y: The IgH 3' regulatory region and its implication in lymphomagenesis. Eur J Immunol 2010;40:3306-3311.
8. Guglielmi L, Le Bert M, Truffinet V, Cogné M, Denizot Y. Insulators to improve expression of a 3'IgH LCR-driven reporter gene in transgenic mouse models. Biochem Biophys Res Commun 2003;307:466-471.
9. Pinaud E, Marquet M, Fiancette R, Péron S, Vincent-Fabert C, Denizot Y, Cogné M: The IgH locus 3' regulatory region: pulling the strings from behind. Adv Immunol 2011;110:27-70
10. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M: Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia. Nat Genet 1999;22:44-52.
11. Lichtman MA: Obesity and the risk for haematological malignancy: leukaemia, lymphoma, or myeloma. The oncologist 2010;15:1083-1101.
12. Post SM, Quintas-Cardama A, Terzian T, Smith C, Eischen CM, Lozano G: p53-dependent senescence delays Eμ-myc-induced B-cell lymphomagenesis. Oncogene 2010;29:1260-1269.
13. Yu M, Zhan Q, Finn OJ: Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53. Mol Immunol 2002;38:981-987.
14. Kidokoro T, Tanikawa C, Furukawa Y, Katagiri T, Nakamura Y, Matsuda K: CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene 2008;27:1562-1571.
15. Hall A: The cytoskeleton and cancer. Cancer Metastasis Rev 2009;28:5-14.
16. Alinari L, Christian B, Baiocchi RA: Novel targeted therapies for mantle cell lymphoma. Oncotarget 2012;2:203-211.